CLASS II ONGOING Drug recall · Reported 2 Apr 2025 · FDA Enforcement Report

Testosterone Gel 1%-dose Packets recalled by Strides Pharma

Strides Pharma is recalling Testosterone Gel 1%-dose Packets in a, distributed nationwide in the US. The recall was initiated on 5 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 5501103A, Exp Mar-25; 5501237A, 5501238A, Exp Apr-25; 5501278A, Exp May-25; 5501280A, 5501342A, Exp Jun-25; 5501372A, Exp Jul-25; 5501496A, Exp Aug-25; 5501499A, Exp Sep-25; 5501580A, Exp Oct-25; 5501582A, Exp Dec-25; 5501653A, 5501656A, Exp Jan-26; 5501770A, Exp Feb-26; 5501842A, 5501868A, 5501882A, Exp Apr-26; 5501957A, Exp May-26; 5502001A, Exp Jul-26; 5502033A, Exp Aug-26; 5502112A, 5502115A, Exp Oct-26; 5502180A, 5502181A, Exp Nov-26.
NDC64380-151, 64380-152
UPC0364380151012, 0364380152019
Quantity recalled244,412 Cartons; 30 sachets /Carton

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0294-2025
FDA event ID
96412
Recalling firm
Strides Pharma, Chestnut Ridge, NY
Manufacturer
Strides Pharma Science Limited
Classification
Class II
Status
Ongoing
Recall initiated
5 Mar 2025
FDA classified
25 Mar 2025
Reported
2 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Benzene

Timeline

5 Mar 2025Recall initiated by company
25 Mar 2025Classified by FDA+20 days
2 Apr 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of foreign substance: Presence of Benzene.

Product as listed by the FDA

Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02

Where it was distributed

Nationwide in the U.S

Nationwide

Questions about this recall

Is Testosterone Gel 1%-dose Packets in a recalled?

Yes. Strides Pharma recalled Testosterone Gel 1%-dose Packets in a on 5 Mar 2025. The recall is Class II and its status is Ongoing. Recall number D-0294-2025.

Why was it recalled?

Presence of foreign substance: Presence of Benzene.

Which lots are affected?

Lot #: 5501103A, Exp Mar-25; 5501237A, 5501238A, Exp Apr-25; 5501278A, Exp May-25; 5501280A, 5501342A, Exp Jun-25; 5501372A, Exp Jul-25; 5501496A, Exp Aug-25; 5501499A, Exp Sep-25; 5501580A, Exp Oct-25; 5501582A, Exp Dec-25; 5501653A, 5501656A, Exp Jan-26; 5501770A, Exp Feb-26; 5501842A, 5501868A, 5501882A, Exp Apr-26; 5501957A, Exp May-26; 5502001A, Exp Jul-26; 5502033A, Exp Aug-26; 5502112A, 5502115A, Exp Oct-26; 5502180A, 5502181A, Exp Nov-26.

Where was it sold?

Nationwide in the U.S

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Strides Pharma

All 13

Other Testosterone recalls

All 16